Funder: National Institutes of Health (NIH)
Due Dates: December 15, 2025 (estimated, forecasted)
Funding Amounts: Award amounts not yet specified; up to 1 Clinical Trial Center and 7 Clinical Centers anticipated; U01 Cooperative Agreement mechanism.
Summary: Supports multi-center precision clinical trials and deep phenotyping in heart failure with preserved ejection fraction (HFpEF) to refine subtypes and develop targeted therapies.
Key Information: Forecasted opportunity—applications not yet solicited; applicants may propose for either the Clinical Trial Center or a Clinical Center.